Page last updated: 2024-09-03

ezogabine and Chronic Disease

ezogabine has been researched along with Chronic Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abd-Elsayed, AA; Gu, JG; Ikeda, R; Jia, Z; Li, M; Ling, J; Zuo, X1
Chabwine, JN; Démonet, JF; du Pasquier, RA; Hirt, L; Kuntzer, T; Michel, P; Rossetti, AR; Schluep, M; Vingerhoets, FG1

Other Studies

2 other study(ies) available for ezogabine and Chronic Disease

ArticleYear
KCNQ channels in nociceptive cold-sensing trigeminal ganglion neurons as therapeutic targets for treating orofacial cold hyperalgesia.
    Molecular pain, 2015, Jul-31, Volume: 11

    Topics: Action Potentials; Animals; Carbamates; Chronic Disease; Cold Temperature; Constriction; Disease Models, Animal; Face; Hyperalgesia; KCNQ Potassium Channels; Male; Molecular Targeted Therapy; Neurons; Nociception; Organoplatinum Compounds; Oxaliplatin; Phenylenediamines; Rats, Sprague-Dawley; Thermosensing; Trigeminal Ganglion

2015
[Neurology].
    Revue medicale suisse, 2012, Jan-11, Volume: 8, Issue:323

    Topics: Antibodies, Monoclonal; Anticonvulsants; Atrial Fibrillation; Carbamates; Chronic Disease; Deep Brain Stimulation; Dopamine Agonists; Epilepsy; Fingolimod Hydrochloride; Genetic Therapy; Humans; Immunosuppressive Agents; Ischemic Attack, Transient; Multiple Sclerosis; Muscular Diseases; Neurology; Parkinson Disease; Phenylenediamines; Polyneuropathies; Propylene Glycols; Sphingosine; Stroke; Treatment Outcome; Valproic Acid

2012